The TBI treatment landscape is evolving through neuroregenerative approaches and advanced monitoring technologies. Leading companies including BioDirection, BrainScope, and Neuren Pharmaceuticals are developing innovative diagnostics and neuroprotective treatments that enhance recovery and reduce long-term disability. Progress in biomarker identification and integrated care models is improving clinical outcomes for this complex neurological injury. View Full Analysis: https://shorturl.at/hFCK6